Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01422902 · ClinicalTrials.gov registry record · Phase 2
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults
A Phase 2 study, sponsored by Posit Science Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT01422902: Completed Phase 2 study, sponsored by Posit Science Corporation.
NCT01422902 is a Phase 2 study that has completed, run by Posit Science Corporation. The registered enrollment target is 150 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (13% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01422902, a Phase 2 study, has completed, sponsored by Posit Science Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
This study is a multi-site, double-blind, randomized, controlled clinical trial to assess the safety and effectiveness of plasticity-based, adaptive, computerized-based cognitive remediation treatment versus a computer-based control. The investigators proposed that a computerized cognitive remediation program based upon the principles of brain plasticity may improve information processing and thus drive clinically significant improvements in cognitive and functional performance in individuals with schizophrenia.
Primary Outcome
Each outcome score (MCCB composite score and UPSA-2 total score) will be analyzed separately. The treatment efficacy will be established if and only if both tests on MCCB and UPSA-2 are significant at two-sided alpha level of 0.05.
Interventions
- OTHER Plasticity-based Cognitive Training
- OTHER Non-plasticity-based Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2012-04 |
| Est. Completion | 2015-06 |
| Phase | Phase 2 |
What the finished NCT01422902 record still lists
NCT01422902 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (13% higher).
The record links to 0 conditions, and to 2 interventions - of which Plasticity-based Cognitive Training is the first listed.
NCT01422902 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01422902 about?
NCT01422902 is a clinical study titled "Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults". This study is a multi-site, double-blind, randomized, controlled clinical trial to assess the safety and effectiveness of plasticity-based, adaptive, computerized-based cognitive remediation treatment versus a computer-based control. The investigators proposed that a computerized cognitive remediat...
What is the current status of trial NCT01422902?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2012-04. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01422902?
The interventions under investigation include: Plasticity-based Cognitive Training (OTHER), Non-plasticity-based Training (OTHER).
Who is sponsoring clinical trial NCT01422902?
This trial is sponsored by Posit Science Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01422902's enrollment target sits among peer trials
150 455th of 2000 higher than 1,510 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia